Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial

European Neuropsychopharmacology

Volumn 16, Issue 5, 2006, Pages 340-349

  Martenyi, Ferenc ^a   Soldatenkova, Victoria ^b  

^a Eli Lilly Area Medical Center   (Austria)

^b InnoPharm Ltd   (Russian Federation)

Author keywords

Acute treatment; Combat related PTSD; Fluoxetine; Placebo; Relapse prevention

Indexed keywords

FLUOXETINE; PLACEBO;

ABDOMINAL PAIN; ACCIDENTAL INJURY; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NERVOUSNESS; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; SHORT FORM 36; SIDE EFFECT; THERAPY EFFECT; TINNITUS; TREATMENT RESPONSE; VETERAN; VOMITING; XEROSTOMIA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; STRESS DISORDERS, POST-TRAUMATIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VETERANS; YUGOSLAVIA;

EID: 33745128388     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.10.007     Document Type: Article

References (50)

1. [APA] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (1952), American Psychiatric Association, Washington, DC
2. [APA] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 2nd ed. (1968), American Psychiatric Association, Washington, DC
3. [APA] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. (1980), American Psychiatric Association, Washington, DC
4. [APA] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
5. Baker D.G., Diamond B.I., Gillette G., Hamner M., Katzelnick D., Kellet T.M., Ellman T.A., Pontius E., Rosenthal M., and Tucker P. A double blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl) 122 4 (1995) 386-389
6. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Klaumnizer G., Charney D.S., and Keane T.M. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav. Ther. 13 (1990) 187-188
7. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., and Keane T.M. The development of a clinician administered PTSD scale. J. Trauma. Stress 8 (1995) 75-90
8. Brady K., Pearlstein T., Asnis G.M., Baker D., Rothbaum B., Sikes C.R., and Farfel G.M. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. A randomized controlled trial. JAMA 283 (2000) 1837-1844
9. Connor K.M., Sutherland S.M., Tupler L.A., Malik M.L., and Davidson J.R.T. Fluoxetine in post-traumatic stress disorder. Br. J. Psychiatry 175 (1999) 17-22
10. DaCosta J.M. On irritable heart: a clinical study of a form of functional cardiac disorder and its consequences. Am. J. Med. Sci. 61 (1871) 17-52
11. Davidson J.R.T., and Colket J.T. The eight item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post traumatic stress disorder. Int. Clin. Psychopharmacol. 12 (1997) 41-45
12. Davidson J.R.T., Kudler H., Smith R., Mahorney S.L., Lipper S., Hammett E., Saunders W.B., and Cavenar J.O. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch. Gen. Psychiatry 47 (1990) 25-266
13. Davidson J.R.T., Kudler H., Saunders W.B., Erickson L., Smith R.D., Stein R.M., Lipper S., Hammett E.B., Mahorney S.L., and Cavenar Jr. J.O. Predicting response to amitriptyline in posttraumatic stress disorder. Am. J. Psychiatry 150 (1993) 1024-1029
14. Davidson J.R.T., Book S.W., Colket J.T., Tupler L.A., Roth S., David D., Hertzberg M., Mellman T., Beckham J.C., Smith R.D., Davidson R.M., Katz R., and Feldman M.E. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol. Med. 27 (1997) 153-160
15. Davidson J.R., Tharwani H.M., and Connor K.M. Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials. Depress. Anxiety 15 2 (2002) 75-78
16. Davis L.L., Lewell M.E., Ambroise S., Farley J., English B., Bartolucci A., and Petty F. A placebo controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder. A preliminary study. J. Clin. Psychopharmacol. 24 3 (2004) 291-297
17. Escalona R., Canive J.M., Calais L.A., and Davidson J.R. Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. Depress. Anxiety 15 1 (2002) 29-33
18. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) (1997), American Psychiatric Press, Washington, DC
19. Frank J.B., Kosten T.R., Giller Jr. E.R., and Dan E. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am. J. Psychiatry 145 (1988) 1289-1291
20. Friedman M.J., Beebe K.L., Dube E.M., and Truman M. Paroxetine effectively treats post-traumatic stress disorder (PTSD) in males. Poster, presented at the ECNP, Barcelona. Eur. Neuropsychopharmacol. 12 S3 (2002) S353
21. Gillin J.C., Smith-Vaniz A., Schnierow B., Rapaport M.H., Kelsoe J., Raimo E., Marler M.R., Goyette L.M., Stein M.B., and Zisook S. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. J. Clin. Psychiatry 62 10 (2001) 789-796
22. Goldberg J., True W., Eisen S., and Henderson W. A twin study of the effects of the Vietnam War on PTSD. JAMA 263 (1990) 1227-1235
23. Guy, W., 1976. ECDEU assessment manual for psychopharmacology, revised. Rockville, MD: National Institute of Mental Health, Psychopharmacology Research Branch, pp. 217-222, 313-331.
24. Hamilton M. The assessment of anxiety states by rating. Br. J. Psychiatry 32 (1959) 50-55
25. Hidalgo R., Hertzberg M.A., Mellman T., Petty F., Tucker P., Wiesler R., Zisook S., Churchill E., and Davidson J. Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int. Clin. Psychopharmacol. 14 (1999) 61-68
26. Kardiner A. War Stress and Neurotic Illness (1941), Paul B. Hober, New York
27. Kardiner A., and Spiegel H. War Stress and Neurotic Illness. 2nd edition (1947), Paul B. Hober, New York
28. Katz R.J., Lott M.H., Arbus P., Crocq L., Herlobsen P., Lingjaerde O., and Lopez O. Pharmacotherapy of post traumatic stress disorder with a novel psychotropic. Anxiety 1 4 (1994) 169-174
29. Kessler R.C., Sonnega A., Bromet E., Hughes M., and Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 52 (1995) 1048-1060
30. Koenen K.C., Harley R., Lyons M.J., Wolfe J., Simpson J.C., Goldberg J., Eisen S.A., and Tsuang M. A twin registry study of familial and individual risk factors for trauma exposure and posttraumatic stress disorder. J. Nerv. Ment. Dis. 190 4 (2002) 209-218
31. Kosten T.R., Frank J.B., Dan E., McDougle C.J., and Giller E.L.Jr. Pharmacotherapy for post traumatic stress disorder using phenelzine or imipramine. J. Nerv. Ment. Dis. 179 6 (1991) 366-370
32. Kulka R.A., Schlenger W.E., Fairbank J.A., Hough R.L., Jordan B.K., Niarma C.R., Weiss D.S., and Grady D.A. Trauma and Vietnam War Generation: Report of Findings from National Vietnam Veterans Readjustment Study (1990), Brunner/Mazel Inc, New York, NY
33. Lewis T. Soldiers Heart and Effort Syndrome (1920), Paul B Hoeber Inc, New York, NY
34. Macklin M.L., Metzger L.J., Litz B.T., McNally R.J., Lasko N.B., Orr S.P., and Pitman R.K. Lower precombat intelligence is a risk factor for posttraumatic stress disorder. J. Consult. Clin. Psychol. 66 2 (1998) 323-326
35. Marshall R.D., Beebe K.L., Oldham M., and Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed dose, placebo controlled study. Am. J. Psychiatry 158 (2001) 1982-1988
36. Martenyi F., Brown E.B., Zhang H., Prakash A., and Koke S.C. Fluoxetine versus placebo in posttraumatic stress disorder. J. Clin. Psychiatry 63 3 (2002) 199-206
37. Martenyi F., Brown E.B., Zhang H., Koke S.C., and Prakash A. Fluoxetine versus placebo in prevention of relapse in post-traumatic stress disorder. Br. J. Psychiatry 181 (2002) 315-320
38. McDougle C.J., Southwick S.M., Charney D.S., and StJames R.L. An open trial of fluoxetine in the treatment of posttraumatic stress disorder. J. Clin. Psychopharmacol. 11 (1991) 325-327
39. Montgomery S.A., and Asberg M.A. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
40. Nagy L.M., Morgan C.A., Southwick S.M., and Charney D.S. Open prospective trial of fluoxetine for posttraumatic stress disorder. J. Clin. Psychopharmacol. 13 (1993) 107-113
41. Reist C., Kauffmann C.D., Haier R.J., Sangdahl C., DeMet E.M., Chicz-DeMet, and Nelson J.N. A controlled trial of desipramine in 18 men with post traumatic stress disorder. Am. J. Psychiatry 146 (1989) 513-516
42. Riskind J.H., Beck A.T., Brown G., and Steer R.A. Taking the measure of anxiety and depression: validity of the reconstructed Hamilton scales. J. Nerv. Ment. Dis. 175 (1987) 474-479
43. Rosner R., Powell S., and Butollo W. Posttraumatic stress disorder three years after the siege of Sarajevo. J. Clin. Psychol. 59 (2003) 41-55
44. SAS Institute Inc. The SAS System for Windows (Release 8.02) (1991). http://www.sas.com www.sas.com
45. Shestatzky M., Greenberg D., and Lerer D. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 24 (1988) 149-155
46. Stein D.J., Davidson J., Seedat S., and Beebe K. Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies. Expert Opin. Pharmacother. 4 10 (2003) 1829-1838
47. Stein D.J., van der Kolk B., Austin C., Fayyad R., and Clay C. Efficacy of sertraline in post-traumatic stress disorder secondary to interpersonal trauma or childhood abuse. Poster presented at the 16th European Congress of Neuropsychopharmacology, September 20-24, Prague. Eur. Neuropsychopharmacol. 13 S4 (2003) S363
48. van der Kolk B.A., Dreyfuss D., Michales M., Shera D., Berkowitz R., Fisler R., and Saxe G. Fluoxetine in posttraumatic stress disorder. J. Clin. Psychiatry 55 (1994) 517-522
49. Ware J.E. The SF-36 health survey. In: Spilker B. (Ed). Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. (1996), Lippincott-Raven, Philadelphia 281-286
50. Zohar J., Amital D., Miodowink C., Kotler M., Bleich A., Lane R.M., and Austin C. Double-blind placebo controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J. Clin. Psychopharmacol. 22 (2002) 190-195